Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — |
| Research & development | $1.0M | $864,999 | $718,505 | $759,510 | $1.0M | $1.2M | $1.1M | $1.3M | $1.3M | $1.8M | $2.7M | $4.0M | $6.0M | $6.9M | $4.8M |
| Operating expenses | $1.4M | $1.3M | $916,292 | $976,656 | $1.3M | $1.6M | $1.6M | $1.6M | $1.5M | $2.0M | $2.9M | $4.3M | $6.5M | $7.2M | $5.0M |
| Operating income | −$1.4M | −$1.3M | −$916,292 | −$976,656 | −$1.3M | −$1.6M | −$1.6M | −$1.6M | −$1.5M | −$2.0M | −$2.9M | −$4.3M | −$6.5M | −$7.2M | −$5.0M |
| EBITDAderived | — | — | — | — | — | — | — | −$1.6M | −$1.5M | −$2.0M | −$2.9M | −$4.3M | −$6.5M | −$7.2M | −$5.0M |
| Net income | −$1.4M | −$1.3M | −$916,292 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic EPSper diluted share | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.02 | -$0.03 | -$0.05 | -$0.05 | -$0.04 |
| Diluted EPSper diluted share | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.02 | -$0.02 | -$0.03 | -$0.05 | -$0.05 | -$0.04 |